Our Pharma Insights Blog
We often hear this common concern from clinical trial managers: “We need a comparator drug…
Blood cancer affects millions of people worldwide, creating a challenging situation. A study predicts that in 2025, 66,890 new cancer cases and 23,540 cancer deaths will occur in the United States due to leukemia.
Recently, a few clinical trial sponsors approached us because they were facing a challenge in distinguishing between a genuine and counterfeit pack of an Immuno-Oncology Drug.
Decentralized Clinical Trials (DCTs) have transformed how clinical trials are conducted. This makes the clinical…
Imagine a scenario where your clinical trial team orders a reference-listed drug with an approved…
Comparator drugs play a pivotal role in determining the quality, efficacy, and safety of the…
Bringing a new drug to market is not a straight path — it’s a long,…
The drug development process is quite complex, consisting of numerous steps. This includes discovering the…
Managing the storage, distribution, and supply chain of pharmaceutical products requiring special storage conditions is…
Managing clinical trial supplies isn’t just a behind-the-scenes task—it plays a crucial role in ensuring…
What Is NCE-1 and How Does It Work? New Chemical Entity (NCE-1) is an application…
What is a New Chemical Entity (NCE)? A New Chemical Entity (NCE) represents a significant…